Skip to main content

AHA, Hospital Leaders Announce 340B Good Stewardship Principles

WASHINGTON, DC (September 18, 2018) – Today, leaders from the American Hospital Association (AHA) and individual 340B hospitals announced new principles for ensuring good stewardship of the 340B program.

 

This new AHA-led initiative will strengthen the 340B program by increasing transparency while helping 340B hospitals better communicate the immense value of the program for vulnerable patients and communities.

 

“The 340B stewardship principles will help hospitals better tell their story of how this crucial program is delivering a variety of important benefits to patients and communities,” said Rick Pollack, president and CEO of the AHA. “In an era of skyrocketing drug prices, 340B has been critical in helping hospitals expand access to comprehensive health services, including lifesaving prescription drugs.”

 

“As president and CEO of the Carilion Clinic, I see firsthand each day that the 340B program helps patients and communities in Virginia,” said Nancy Agee, president and CEO of Carilion Clinic, chair of the AHA and a member of the AHA 340B Board Task Force. “These good stewardship principles will continue to strengthen the 340B program and help policymakers, other stakeholders, and the public better understand the immense value of 340B for patient care.”

“The 340B program has helped deliver immense benefits to the rural South Carolina communities that Tidelands Health is proud to serve, including free care to uninsured patients, community programs to promote health and wellbeing, and professional hospital pharmacy services 24/7 for all patients,” said Bruce Bailey, president and CEO of Tidelands Health and chair of the AHA 340B Board Task Force. “These new principles will help 340B hospitals across the country communicate why this vital program is so important to their patients and communities.”

“340B helps provide a range of health care services to Maine’s underserved and uninsured patients and communities,” said Michelle Hood, president and CEO of Eastern Maine Healthcare Systems and a member of the AHA 340B Board Task Force. “Providing good stewardship of the 340B program will help ensure that participating hospitals can offer these comprehensive services that expand patient access to care.”

“The importance of the 340B Program to UC San Diego Health has demanded strong stewardship,” said Dr. Charles Daniels, pharmacist-in-chief for UC San Diego Health and a member of the AHA 340B Board Task Force. “These stewardship principles are at the core of our 340B operations. Continuing access to this vital program will allow UC San Diego Health to provide medical care to many underserved patients in a variety of different capacities.”

The following principles released today serve as the foundation for every 340B hospital’s good stewardship of the program:

  • Communicate the Value of the 340B Program: The hospital commits to preparing and publishing a narrative, on an annual basis, that describes how it uses 340B savings to benefit the community. The narrative would address those programs and services funded, in whole or in part, by 340B savings, including those services that support community access to care that the hospital could not continue without 340B savings. Examples of such programs and services will be particular for each hospital and could include programs that expand access to drugs for vulnerable populations, as well as a wide range of other services, such as preventive care, emergency services, cancer treatment, vaccinations, home-based care, and mental and behavioral health services.
     
  • Disclose Hospital’s 340B Estimated Savings: The hospital commits to publicly disclosing, on an annual basis, its 340B estimated savings calculated using a standardized method. That method would calculate 340B savings by comparing the 340B acquisition price to group purchasing organization (GPO) pricing. If GPO pricing is not available for a 340B drug, the 340B acquisition price for a drug would be compared to another acceptable pricing source. To provide context for the estimated savings, hospitals could compare their 340B estimated savings to the hospitals’ total drug expenditures, as well as provide examples of their top 340B drugs. |
     
  • Continue Rigorous Internal Oversight. The hospital commits to continuing to conduct internal reviews to ensure that the hospital’s 340B program meets HRSA program rules and guidance. Included in this effort is a commitment to regular and periodic training for their interdisciplinary 340B teams that encompasses C-suite executives, pharmacy, legal, and financial assistance, as well as community outreach and government relations staff if applicable.

The good stewardship principles have been endorsed by America’s Essential Hospitals, the Association of American Medical Colleges, the Catholic Health Association of the United States, the Children’s Hospital Association and 340B Health.
 

For additional information about the 340B program, including the good stewardship principles, visit HERE.

 

Contact: 

 

Colin Milligan, 202-638-5491, cmilligan@aha.org
Marie Johnson, 202-626-2351, mjohnson@aha.org

 

###

 

About the American Hospital Association

The AHA is a not-for-profit association of health care provider organizations and individuals that are committed to the health improvement of their communities. The AHA is the national advocate for its members, which include nearly 5,000 hospitals, health care systems, networks, other providers of care and 43,000 individual members. Founded in 1898, the AHA provides education for health care leaders and is a source of information on health care issues and trends. For more information, visit the AHA website at www.aha.org.

 

Related Resources

Special Bulletin
Member
The Department of Health and Human Services today issued a final rule making Jan. 1 the effective date of its final regulations on drug ceiling prices and…
Press Releases
Letter
The AHA urges the Health Resources and Services Administration to meet the Jan. 1 effective date it has proposed for its final rule on drug ceiling prices and…
Advisory
Member
On Nov.
Press Releases
Press Releases